Contact
Please use this form to send email to PR contact of this press release:
CTD Holdings Discusses its Phase I Clinical Trial for Intravenous Use of Trappsol® Cyclo™ in Niemann-Pick Disease Type C
TO:
Please use this form to send email to PR contact of this press release:
CTD Holdings Discusses its Phase I Clinical Trial for Intravenous Use of Trappsol® Cyclo™ in Niemann-Pick Disease Type C
TO: